title: Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
authors.forename: Emel Bulbul
authors.initials: EB
authors.lastname: Baskan
authors.forename: Sükran
authors.initials: S
authors.lastname: Tunali
authors.forename: Saduman Balaban
authors.initials: SB
authors.lastname: Adim
authors.forename: Murat
authors.initials: M
authors.lastname: Kiyici
authors.forename: Ridvan
authors.initials: R
authors.lastname: Ali
mesh_terms: D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D019253:Proto-Oncogene Proteins c-bcl-2; D017239:Paclitaxel